Net loss per share

3 Months Ended

Jun. 30, 2024

Basic and diluted net loss per share attributable to common stockholders was calculated as follows:


	Three Months Ended June 30,
	2024		2023
Numerator:
Net loss	$	(53,772)	$	(49,555)
Denominator:
Weighted average common shares outstanding, basic and diluted	69,185,885		66,367,702
Net loss per share, basic and diluted	$	(0.78)	$	(0.75)

The 10,211,969 shares of the Company's common stock issuable upon exercise of pre-funded warrants described in Note 9 to these consolidated financial statements are included as outstanding common stock in the calculation of basic and diluted net loss per share.

The Company’s potentially dilutive securities, which include stock options, unvested restricted and performance stock units and warrants to purchase shares of common stock that resulted from the conversion of warrants to purchase shares of series seed preferred stock existing before the Company's IPO, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:


	Three Months Ended June 30,
	2024	2023
Options to purchase common stock	10,157,054	9,067,305
Unvested restricted and performance stock units	3,370,183	2,069,415
Warrants to purchase common stock	497,344	497,344
	14,024,581	11,634,064